Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
Indiana University – Purdue University Indianapolis · The University of Texas Southwestern Medical Center
Abstract
PURPOSE: Surgical resection is standard therapy in stage I non-small-cell lung cancer (NSCLC); however, many patients are inoperable due to comorbid diseases. Building on a previously reported phase I trial, we carried out a prospective phase II trial using stereotactic body radiation therapy (SBRT) in this population. PATIENTS AND METHODS: Eligible patients included clinically staged T1 or T2 (
Citation impact
- FWCI
- 45.38
- Percentile
- 100%
- References
- 48
Authors
11- RTRobert TimmermanCorresponding
Indiana University – Purdue University Indianapolis, The University of Texas Southwestern Medical Center
- RCRonald C. McGarry
Indiana University – Purdue University Indianapolis, The University of Texas Southwestern Medical Center
- CTConstantin T. Yiannoutsos
Indiana University – Purdue University Indianapolis, The University of Texas Southwestern Medical Center
- LPLech Papież
Indiana University – Purdue University Indianapolis, The University of Texas Southwestern Medical Center
- KTK. Tudor
Indiana University – Purdue University Indianapolis, The University of Texas Southwestern Medical Center
Topics & keywords
- Medicine
- Lung cancer
- Stage (stratigraphy)
- Toxicity
- Radiation therapy
- Oncology
- Cancer
- Lung
- Good health and well-being